Haisco Pharmaceutical Group Co Ltd (002653)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014240
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company’s product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble vitamins, long-chain fat emulsion, compound amino acid among others. Its products include parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. It conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 12
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 13
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 14
Microbion Enters into Agreement with Xizang Haisco Pharma 15
Equity Offering 16
Microbion Raises Funds through Private Placement of Shares 16
Xizang Haisco Pharma Completes IPO For US$127 Million 17
Debt Offering 18
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 18
Acquisition 19
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 19
Haisco Pharmaceutical Group Co Ltd – Key Competitors 20
Haisco Pharmaceutical Group Co Ltd – Key Employees 21
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Haisco Pharmaceutical Group Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 12
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 13
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 14
Microbion Enters into Agreement with Xizang Haisco Pharma 15
Microbion Raises Funds through Private Placement of Shares 16
Xizang Haisco Pharma Completes IPO For US$127 Million 17
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 18
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 19
Haisco Pharmaceutical Group Co Ltd, Key Competitors 20
Haisco Pharmaceutical Group Co Ltd, Key Employees 21
Haisco Pharmaceutical Group Co Ltd, Other Locations 22
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 22

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invenergy LLC:発電所・企業SWOT分析
    Invenergy LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • BASF Corp-エネルギー分野:企業M&A・提携分析
    Summary BASF Corp (BASF), a subsidiary of BASF SE, is a chemical manufacturing company. Its product portfolio includes petrochemicals, monomers, intermediates, dispersions and pigments, care chemicals, nutrition and health products, paper chemicals, performance chemicals, catalysts, construction che …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Progenics Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Progenics Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Progenics Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • EnerSys (ENS):電力:M&Aディール及び事業提携情報
    Summary EnerSys is a provider of stored energy solutions. It manufactures, markets, and distributes reserve power and motive power batteries, power equipment, battery accessories, battery chargers, and outdoor equipment enclosure solutions. The company also related aftermarket and customer-support s …
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive in …
  • Yangarra Resources Ltd (YGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • ResCare Inc:企業の戦略的SWOT分析
    ResCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aditya Birla Sun Life Insurance Company Limited:企業の戦略・SWOT・財務分析
    Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • CNP Cyprialife Ltd:企業の戦略的SWOT分析
    CNP Cyprialife Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Intellect Design Arena Limited:戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Virgin Media Inc:企業の戦略的SWOT分析
    Virgin Media Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Invenra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, mi …
  • Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):企業のM&A・事業提携・投資動向
    Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes b …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • Femasys Inc:製品パイプライン分析
    Summary Femasys Inc (Femasys) is a medical device company that offers solutions for women’s healthcare. The company provides products for permanent contraception, infertility solutions and cancer diagnosis. It offers products such as femvue saline-air device, fembloc permanent contraceptive system a …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • SPX Corp (SPXC):電力:M&Aディール及び事業提携情報
    Summary SPX Corp (SPX) is a specialized engineered solutions provider. It offers highly engineered products, technologies, and solutions. The company’s portfolio includes heating, ventilation, and air conditioning (HVAC) products, detection and measurement equipment, and engineered solutions. It off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆